{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1382825895173547136.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Paul J. Dyson"}],"foaf:familyName":[{"@value":"Dyson"}],"foaf:givenName":[{"@value":"Paul J."}]}],"career":[{"institution":{"notation":[{"@value":"Institut des Sciences et Ingénierie Chimiques, Ecole Polytechnique Fédérale de Lausanne (EPFL), CH 1015 Lausanne, Switzerland, Institut de Minéralogie et Géochimie, Université de Lausanne (UNIL), CH 1015 Lausanne, Switzerland, and University Institute of Pathology, Centre Hospitalier Universitaire Vaudois (CHUV), CH 1011 Lausanne, Switzerland"}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1362825895173547136","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1021/jm0506468"},{"@type":"URI","@value":"https://pubs.acs.org/doi/pdf/10.1021/jm0506468"}],"notation":[{"@value":"Synthesis and Characterization of Platinum(IV) Anticancer Drugs with Functionalized Aromatic Carboxylate Ligands:  Influence of the Ligands on Drug Efficacies and Uptake"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1021/jm0506468_ERpLr9pkJTSZSZmCdxlwoHdDyCx"}]}